Cargando…
15. Is Certolizumab a better option in treatment of psoriatic patients with active joint and skin involvement?
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6652631/ http://dx.doi.org/10.1093/rap/rkx006 |
| _version_ | 1783438558007132160 |
|---|---|
| author | McVey, Aoife Rahiman, Imna Fazel Chiu, Yeeho |
| author_facet | McVey, Aoife Rahiman, Imna Fazel Chiu, Yeeho |
| author_sort | McVey, Aoife |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6652631 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-66526312019-08-20 15. Is Certolizumab a better option in treatment of psoriatic patients with active joint and skin involvement? McVey, Aoife Rahiman, Imna Fazel Chiu, Yeeho Rheumatol Adv Pract A. POSTER CASE REPORTS Oxford University Press 2017-11-14 /pmc/articles/PMC6652631/ http://dx.doi.org/10.1093/rap/rkx006 Text en © The Author 2017. Published by Oxford University Press on behalf of the British Society for Rheumatology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| spellingShingle | A. POSTER CASE REPORTS McVey, Aoife Rahiman, Imna Fazel Chiu, Yeeho 15. Is Certolizumab a better option in treatment of psoriatic patients with active joint and skin involvement? |
| title | 15. Is Certolizumab a better option in treatment of psoriatic patients with active joint and skin involvement? |
| title_full | 15. Is Certolizumab a better option in treatment of psoriatic patients with active joint and skin involvement? |
| title_fullStr | 15. Is Certolizumab a better option in treatment of psoriatic patients with active joint and skin involvement? |
| title_full_unstemmed | 15. Is Certolizumab a better option in treatment of psoriatic patients with active joint and skin involvement? |
| title_short | 15. Is Certolizumab a better option in treatment of psoriatic patients with active joint and skin involvement? |
| title_sort | 15. is certolizumab a better option in treatment of psoriatic patients with active joint and skin involvement? |
| topic | A. POSTER CASE REPORTS |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6652631/ http://dx.doi.org/10.1093/rap/rkx006 |
| work_keys_str_mv | AT mcveyaoife 15iscertolizumababetteroptionintreatmentofpsoriaticpatientswithactivejointandskininvolvement AT rahimanimnafazel 15iscertolizumababetteroptionintreatmentofpsoriaticpatientswithactivejointandskininvolvement AT chiuyeeho 15iscertolizumababetteroptionintreatmentofpsoriaticpatientswithactivejointandskininvolvement |